Sartorius Stedim Biotech SA
PAR:DIM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Sartorius Stedim Biotech SA
Interest Income Expense
Sartorius Stedim Biotech SA
Interest Income Expense Peer Comparison
Sartorius Stedim Biotech SA
Glance View
Sartorius Stedim Biotech makes tools and consumable products used to develop and manufacture biologic drugs. Its main products include filters, bags, tubing, fermentation and cell-culture equipment, and lab instruments that help scientists grow cells, separate liquids, and keep production sterile. It is a supplier to the life-science supply chain rather than a drug maker itself. Its main customers are biotech and pharmaceutical companies, contract drug manufacturers, and research labs that work on vaccines, antibodies, and other biologic medicines. The company makes money by selling equipment, but a big part of its business comes from repeat sales of disposable items and other consumables that customers need throughout development and production. What makes the business model distinct is that it sits in the “picks and shovels” part of biologic drug manufacturing. Customers often use its single-use systems because they can reduce cleaning, speed up changeovers, and lower contamination risk. That gives the company a durable role in an industry where safety, purity, and reliable process equipment matter a lot.
See Also
What is Sartorius Stedim Biotech SA's Interest Income Expense?
Interest Income Expense
-156.6m
EUR
Based on the financial report for Mar 31, 2026, Sartorius Stedim Biotech SA's Interest Income Expense amounts to -156.6m EUR.
What is Sartorius Stedim Biotech SA's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-42%
Over the last year, the Interest Income Expense growth was -9%.